Crossref
Where does the development of new antituberculotics go? Part 2 - In vitro evaluation
Česká a slovenská farmacie · 2014
DOI: 10.36290/csf.2014.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Česká a slovenská farmacie, 2014. Verfasst von Karel Waisser. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Waisser, K. (2014). Where does the development of new antituberculotics go? Part 2 - In vitro evaluation. Česká a slovenská farmacie. https://doi.org/10.36290/csf.2014.003
Vancouver
Waisser K. Where does the development of new antituberculotics go? Part 2 - In vitro evaluation. Česká a slovenská farmacie. 2014. doi:10.36290/csf.2014.003
BibTeX
@article{Waisser2014,
author = {Waisser, Karel},
title = {Where does the development of new antituberculotics go? Part 2 - In vitro evaluation},
journal = {Česká a slovenská farmacie},
year = {2014},
doi = {10.36290/csf.2014.003}
}
EUVIMED